PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
78.09
+0.03 (0.04%)
Jul 15, 2026, 10:43 AM EDT - Market open
PTC Therapeutics Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, PTC Therapeutics stock has a consensus rating of "Buy" and an average price target of $94.29. The average 1-year stock price forecast is 20.75% higher than the current stock price, while the lowest is $65 (-16.76%) and the highest is $124 (+58.79%).
Price Target: $94.29 (+20.75%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PTC Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 5 | 6 | 7 | 7 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 4 | 5 | 5 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 14 | 14 | 15 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Reiterates $93 → $95 | Buy | Reiterates | $93 → $95 | +21.65% | Jul 15, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $89 → $91 | Buy | Maintains | $89 → $91 | +16.53% | Jul 13, 2026 |
| Barclays | Barclays | Buy Maintains $120 | Buy | Maintains | $120 | +53.67% | Jul 8, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $82 → $85 | Hold | Maintains | $82 → $85 | +8.85% | Jul 7, 2026 |
| Citi | Citi | Buy Initiates $75 → $108 | Buy | Initiates | $75 → $108 | +38.30% | Jun 9, 2026 |
Financial Forecast
Revenue This Year
1.17B
from 1.73B
Decreased by -32.13%
Revenue Next Year
1.34B
from 1.17B
Increased by 13.95%
EPS This Year
1.49
from 7.62
Decreased by -80.45%
EPS Next Year
3.09
from 1.49
Increased by 107.16%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.3B | ||
| Avg | 1.2B | ||
| Low | 1.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -25.1% | ||
| Avg | -32.1% | ||
| Low | -37.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.91 | ||
| Avg | 1.49 | ||
| Low | 0.85 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -74.9% | ||
| Avg | -80.5% | ||
| Low | -88.8% |